Form4insider filings, from the source

SEC Form 4 · accession 0001140361-16-088016

ENZON PHARMACEUTICALS, INC. · ENZN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Carl C Icahn
10% Owner
Period of report
Nov 28, 2016
Accepted (ET)
Nov 29, 2016 · 11:18 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727510

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3,F4,F5Nov 28, 2016P694,023$0.405A6,598,886Iplease see footnotes

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Total Return SwapF6,F7,F8,F1,F2,F3,F4,F5$1.09Nov 28, 2016H1D—Nov 28, 2016Common Stock694,0230I

Explanation of responses